Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference.
Journal
Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
entrez:
8
1
2020
pubmed:
8
1
2020
medline:
2
10
2020
Statut:
ppublish
Résumé
From September 25 to 28, 2019, in Paris, France, the Fifth International Cancer Immunotherapy Conference was hosted jointly by the Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research. This year, roughly 1,300 people attended the 4-day event, which covered the latest advances in cancer immunology and immunotherapy.
Identifiants
pubmed: 31909729
pii: 8/1/3
doi: 10.1158/2326-6066.CIR-19-0888
doi:
Substances chimiques
Antineoplastic Agents, Immunological
0
Immunologic Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3-6Informations de copyright
©2020 American Association for Cancer Research.